Brian A. Crowe

1.7k total citations
42 papers, 1.3k citations indexed

About

Brian A. Crowe is a scholar working on Epidemiology, Microbiology and Molecular Biology. According to data from OpenAlex, Brian A. Crowe has authored 42 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 12 papers in Microbiology and 11 papers in Molecular Biology. Recurrent topics in Brian A. Crowe's work include Influenza Virus Research Studies (12 papers), Bacterial Infections and Vaccines (11 papers) and Pneumonia and Respiratory Infections (6 papers). Brian A. Crowe is often cited by papers focused on Influenza Virus Research Studies (12 papers), Bacterial Infections and Vaccines (11 papers) and Pneumonia and Respiratory Infections (6 papers). Brian A. Crowe collaborates with scholars based in Austria, Germany and United States. Brian A. Crowe's co-authors include Mark Achtman, T. Olyhoek, Perry Barrett, Helga Savidis-Dacho, Jan Poolman, Barica Kušećek, Michael G. Schwendinger, Otfried Kistner, Falko G. Falkner and P Brühl and has published in prestigious journals such as The Journal of Experimental Medicine, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Brian A. Crowe

42 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brian A. Crowe Austria	19	723	572	331	300	225	42	1.3k
Barbara Capecchi Italy	14	577 0.8×	655 1.1×	119 0.4×	266 0.9×	138 0.6×	20	984
Silvana Savino Italy	19	834 1.2×	1.0k 1.8×	183 0.6×	399 1.3×	320 1.4×	32	1.5k
Laura Santini Italy	20	1.2k 1.6×	1.2k 2.2×	264 0.8×	458 1.5×	378 1.7×	45	1.9k
O Barrera United States	16	553 0.8×	948 1.7×	191 0.6×	449 1.5×	242 1.1×	18	1.6k
M S Peppler Canada	23	640 0.9×	1.1k 1.9×	206 0.6×	436 1.5×	165 0.7×	38	1.6k
Sheena M. Loosmore Canada	16	407 0.6×	332 0.6×	332 1.0×	224 0.7×	100 0.4×	32	954
Nicholas J. Parsons United Kingdom	19	303 0.4×	813 1.4×	124 0.4×	309 1.0×	221 1.0×	43	1.2k
Daniela Hozbor Argentina	26	1.3k 1.7×	1.5k 2.6×	324 1.0×	374 1.2×	169 0.8×	90	2.0k
Daniel Hogan United States	17	523 0.7×	865 1.5×	555 1.7×	289 1.0×	336 1.5×	19	1.8k
S J Devi United States	14	1.1k 1.5×	705 1.2×	410 1.2×	132 0.4×	278 1.2×	19	1.4k

Countries citing papers authored by Brian A. Crowe

Since Specialization

Citations

This map shows the geographic impact of Brian A. Crowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian A. Crowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian A. Crowe more than expected).

Fields of papers citing papers by Brian A. Crowe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian A. Crowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian A. Crowe. The network helps show where Brian A. Crowe may publish in the future.

Co-authorship network of co-authors of Brian A. Crowe

This figure shows the co-authorship network connecting the top 25 collaborators of Brian A. Crowe. A scholar is included among the top collaborators of Brian A. Crowe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian A. Crowe. Brian A. Crowe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Modak, Madhura, Claire Battin, Peter Steinberger, et al.. (2021). The soluble cytoplasmic tail of CD45 regulates T‐cell activation via TLR4 signaling. European Journal of Immunology. 51(12). 3176–3185. 7 indexed citations

Carestia, Agostina, Seok‐Joo Kim, Hanspeter Rottensteiner, et al.. (2020). Modulation of the liver immune microenvironment by the adeno-associated virus serotype 8 gene therapy vector. Molecular Therapy — Methods & Clinical Development. 20. 95–108. 16 indexed citations

Schwendinger, Michael G., Helga Savidis-Dacho, Brian A. Crowe, et al.. (2015). Immunogenicity and Protective Efficacy of a Vero Cell Culture-Derived Whole-Virus H7N9 Vaccine in Mice and Guinea Pigs. PLoS ONE. 10(2). e0113963–e0113963. 18 indexed citations

Wressnigg, Nina, Perry Barrett, Daniel Portsmouth, et al.. (2014). A Novel Multivalent OspA Vaccine against Lyme Borreliosis Is Safe and Immunogenic in an Adult Population Previously Infected with Borrelia burgdorferi Sensu Lato. Clinical and Vaccine Immunology. 21(11). 1490–1499. 32 indexed citations

Wutte, Nora, Juan J. Archelos, Brian A. Crowe, et al.. (2014). Laboratory diagnosis of Lyme neuroborreliosis is influenced by the test used: Comparison of two ELISAs, immunoblot and CXCL13 testing. Journal of the Neurological Sciences. 347(1-2). 96–103. 5 indexed citations

Smith, Larry, Brian A. Crowe, Michael G. Schwendinger, et al.. (2013). Preclinical evaluation of Vaxfectin^®-adjuvanted Vero cell-derived seasonal split and pandemic whole virus influenza vaccines. Human Vaccines & Immunotherapeutics. 9(6). 1333–1345. 8 indexed citations

Sabarth, Nicolas, Helga Savidis-Dacho, Michael G. Schwendinger, et al.. (2012). A cell culture-derived whole-virus H5N1 vaccine induces long-lasting cross-clade protective immunity in mice which is augmented by a homologous or heterologous booster vaccination. Vaccine. 30(37). 5533–5540. 5 indexed citations

Livey, Ian, Andreas Traweger, Helga Savidis-Dacho, et al.. (2011). A New Approach to a Lyme Disease Vaccine. Clinical Infectious Diseases. 52(suppl_3). s266–s270. 29 indexed citations

Schäfer, Birgit, Georg W. Holzer, Michael G. Schwendinger, et al.. (2011). Pre-Clinical Efficacy and Safety of Experimental Vaccines Based on Non-Replicating Vaccinia Vectors against Yellow Fever. PLoS ONE. 6(9). e24505–e24505. 25 indexed citations

10.

Schwendinger, Michael G., Georg W. Holzer, Nicolas Sabarth, et al.. (2010). A Pandemic Influenza H1N1 Live Vaccine Based on Modified Vaccinia Ankara Is Highly Immunogenic and Protects Mice in Active and Passive Immunizations. PLoS ONE. 5(8). e12217–e12217. 30 indexed citations

11.

Maurik, André van, Nicolas Sabarth, P Brühl, et al.. (2009). Seasonal influenza vaccine elicits heterosubtypic immunity against H5N1 that can be further boosted by H5N1 vaccination. Vaccine. 28(7). 1778–1785. 16 indexed citations

12.

Kistner, Otfried, M. Keith Howard, Martin Spruth, et al.. (2007). Cell culture (Vero) derived whole virus (H5N1) vaccine based on wild-type virus strain induces cross-protective immune responses. Vaccine. 25(32). 6028–6036. 87 indexed citations

13.

Weiss, Richard, Sven Mostböck, Sandra Scheiblhofer, et al.. (1999). Improvement of the immune response against plasmid DNA encoding OspC of Borrelia by an ER-targeting leader sequence. Vaccine. 18(9-10). 815–824. 25 indexed citations

14.

Gerenčer, Marijan, et al.. (1998). The role of complement and gp120-specific antibodies in virus lysis and CD4+ T cell depletion in HIV-1-infected patients. Microbial Pathogenesis. 25(5). 253–266. 8 indexed citations

15.

Achtman, Mark, Barica Kušećek, Giorgio Morelli, et al.. (1992). A Comparison of the Variable Antigens Expressed by Clone IV-1 and Subgroup III of Neisseria meningitidis Serogroup A. The Journal of Infectious Diseases. 165(1). 53–68. 74 indexed citations

16.

Crowe, Brian A., Barica Kušećek, Bernd Neumann, et al.. (1989). Clonal and Variable Properties of Neisseria meningitidis Isolated from Cases and Carriers During and After an Epidemic in The Gambia, West Africa. The Journal of Infectious Diseases. 159(4). 686–700. 77 indexed citations

17.

Abdillahi, H, Brian A. Crowe, Mark Achtman, & Jan Poolman. (1988). Two monoclonal antibodies specific for serotype 4 antigen ofNeisseria meningitidis. European Journal of Clinical Microbiology & Infectious Diseases. 7(2). 293–296. 16 indexed citations

18.

Achtman, M., Brian A. Crowe, Wolfgang Strittmatter, et al.. (1988). Purification and characterization of eight class 5 outer membrane protein variants from a clone of Neisseria meningitidis serogroup A.. The Journal of Experimental Medicine. 168(2). 507–525. 140 indexed citations

19.

Olyhoek, T., Brian A. Crowe, R.A. Wall, & Mark Achtman. (1988). Comparison of clonal analysis and DNA restriction analysis for typing of Neisseria meningitidis. Microbial Pathogenesis. 4(1). 45–51. 14 indexed citations

20.

Crowe, Brian A., Peter Owen, Daulat S. Patil, & Richard Cammack. (1983). Characterization of succinate dehydrogenase from Micrococcus luteus (lysodeikticus) by electron‐spin‐resonance spectroscopy. European Journal of Biochemistry. 137(1-2). 191–196. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact